Dr. Audry Kang, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24900 Se Stark St Ste 103, Gresham, OR 97030 Phone: 503-935-8088 Fax: 503-935-8082 |
Kent C Toland, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 24076 Se Stark St Ste 310, Gresham, OR 97030 Phone: 503-492-6510 |
Dr. Melanie Ann Crites-bachert, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 24076 Se Stark St, Suite 310, Gresham, OR 97030 Phone: 503-492-6510 Fax: 503-492-6502 |
Dr. Shammai Rockove, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24076 Se Stark St, Suite 310, Gresham, OR 97030 Phone: 503-492-6510 Fax: 503-492-6502 |
Dr. Brian Matthew Blair, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24900 Se Stark St Ste 103, Gresham, OR 97030 Phone: 503-935-8088 |
Dr. Robert L Kalez, MD PC Urology Medicare: Not Enrolled in Medicare Practice Location: 24900 Se Stark St Ste 208, Gresham, OR 97030 Phone: 503-666-3030 Fax: 503-666-3434 |
News Archive
Sleeping woes may explain why children with epilepsy are often so hyperactive, say researchers with the University of Florida's Evelyn F. and William L. McKnight Brain Institute.
Christian Griesinger, director of the NMR-based Structural Biology department at the Max-Planck Institute for Biophysical Chemistry, talks about his research into neurodegenerative diseases using NMR to examine the dynamics of disordered proteins.
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has shown that a protein found in fat cells is a newly discovered cause of insulin resistance, establishing a previously unidentified molecular link between obesity and type 2 diabetes and offering a potential new target for the development of drugs to treat diabetes.
THE long-held belief that Omega-3 fats can help reduce chronic lung disease in pre-term babies has been debunked by researchers.
Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.
› Verified 6 days ago